MyBody-X angle on FTO Kinder

The FTO genotype (e.g., rs9939609) is the most replicated genetic marker for BMI and obesity risk. In children, the risk variant (A-allele) shows a moderate association with higher body fat and increased appetite, especially for energy-dense foods. However, a single SNP explains only about 0.3–1% of BMI variation. Effects are polygenic and strongly environment-dependent. A MyBody-X test can determine the genotype but cannot diagnose obesity. Clinical relevance is limited: without accompanying biomarkers (e.g., leptin, insulin) or family history, the interpretation remains vague. Evidence: human-strong for association, not for causality or individual prediction. Caveat: Do not derive dietary or lifestyle recommendations from FTO alone. Instead, consider the child holistically – physical activity, sleep, stress, and family habits are key. MyBody-X positions itself as an educational, not diagnostic tool.